An Open-labeled Trial of Ramipril in Patients With Migraine

Mise à jour : Il y a 4 ans
Référence : NCT01402479

Femme et Homme

Extrait

Physiology of migraine involving renin-angiotensin systems (RAS) has been implicated. Ramipril is a broadly-used angiotensin-converting enzyme inhibitor. The investigators attempt to test the efficacy of ramipril on the prophylaxis of migraine attacks.


Critère d'inclusion

  • Migraine With Hypertension

Liens